Fredericus Colen

Fredericus Antonius Colen currently works at Xeltis AG, as Chairman from 2023, College of Science & Engineering, as Director, and ONWARD Medical SA, as Director from 2017.
Mr. Colen also formerly worked at BeneChill, Inc., as Chairman, President & Chief Executive Officer from 2014 to 2016, Acarix AB, as Chief Executive Officer from 2023 to 2024, Neovasc, Inc., as President & Chief Executive Officer from 2018 to 2023, Mölnlycke Health Care AB, as Director from 2012 to 2017, Middle Peak Medical, Inc., as Independent Director from 2015 to 2017, Volato Group, Inc., as Independent Director in 2024, GTX medical BV, as Independent Non-Executive Director from 2017 to 2024, SCIMED Life Systems, Inc. (Minnesota), as VP-Cardiovascular Research & Development, Boston Scientific Corp., as Chief Technology Officer & Executive VP from 2001 to 2010, Cardiac Rhythm Management, as President from 2008 to 2010, and International Association of Medical Prosthesis Manufacturers, as Vice President from 1995 to 1997.
Mr. Colen received his graduate degree from RWTH Aachen University.